Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

It has happened to me and my colleagues far too often: watching a patient die from complications of COVID-19. While the ultimate cause of...

Curing disease, growing organs, and even teaching organoids to play a computer game are sending seismic waves of hope within the research community as the potential increases exponentially.

I do not wish a breakthrough infection on anyone. If one does get a breakthrough, though, the silver lining is that the immunity after such infection is very, very robust.